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Background: Nearly five percent of Americans suffer from functional constipation, many of whom may benefit
from increasing dietary fiber consumption. The annual constipation-related healthcare cost savings associated with
increasing intakes may be considerable but have not been examined previously. The objective of the present study
was to estimate the economic impact of increased dietary fiber consumption on direct medical costs associated
with constipation.
Methods: Literature searches were conducted to identify nationally representative input parameters for the U.S.
population, which included prevalence of functional constipation; current dietary fiber intakes; proportion of the
population meeting recommended intakes; and the percentage that would be expected to respond, in terms of
alleviation of constipation, to a change in dietary fiber consumption. A dose–response analysis of published data
was conducted to estimate the percent reduction in constipation prevalence per 1 g/day increase in dietary fiber
intake. Annual direct medical costs for constipation were derived from the literature and updated to U.S. $ 2012.
Sensitivity analyses explored the impact on adult vs. pediatric populations and the robustness of the model to each
input parameter.
Results: The base case direct medical cost-savings was $12.7 billion annually among adults. The base case assumed
that 3% of men and 6% of women currently met recommended dietary fiber intakes; each 1 g/day increase in
dietary fiber intake would lead to a reduction of 1.9% in constipation prevalence; and all adults would increase their
dietary fiber intake to recommended levels (mean increase of 9 g/day). Sensitivity analyses, which explored numerous
alternatives, found that even if only 50% of the adult population increased dietary fiber intake by 3 g/day, annual
medical costs savings exceeded $2 billion. All plausible scenarios resulted in cost savings of at least $1 billion.
Conclusions: Increasing dietary fiber consumption is associated with considerable cost savings, potentially
exceeding $12 billion, which is a conservative estimate given the exclusion of lost productivity costs in the model.
The finding that $12.7 billion in direct medical costs of constipation could be averted through simple, realistic
changes in dietary practices is promising and highlights the need for strategies to increase dietary fiber intakes.
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Current dietary fiber intakes in the United States are far
below recommended levels [1], with recent estimates in-
dicating that less than three percent of men and only six
percent of women meet recommendations [2]. Although
a universally-accepted definition of dietary fiber does not
exist, the Institute of Medicine (IOM) defines dietary
fiber as nondigestible carbohydrates and lignin that are
intrinsic (i.e., naturally occurring) and intact in plants
[1]. To increase dietary fiber intakes, the Dietary Guide-
lines for Americans, 2010 [3] recommends that Americans
should select fiber-rich foods such as whole grains, vegeta-
bles, fruits, and beans and peas, while limiting refined
grains. In particular, the Dietary Guidelines specify that at
least half of all grains consumed should be whole grains.
Accumulating evidence suggests that greater dietary fiber
intakes reduce risk for type 2 diabetes [4,5], cardiovascular
disease [5-7], certain cancers [8-10], weight gain [11,12],
diverticular disease [13,14], and obesity [11], as well as
functional constipation [15-20].
Reports of the prevalence of functional constipation,
also referred to as chronic idiopathic constipation, vary
widely, ranging from 1.9 to 27.1% in the general U.S.
population [21,22]. These variations result from differ-
ences in important factors such as how constipation is de-
fined and how cases are ascertained (e.g., self-report vs.
clinical evaluation). Overall, prevalence of functional con-
stipation increases with advancing age and occurs more
frequently in women than men [21]. According to the
most recent set of Rome diagnostic criteria (Rome III),
which are the most widely accepted criteria [23] functional
constipation is characterized by defecation associated with
straining, hard stools, a sensation of incomplete evacu-
ation, a sensation of anorectal obstruction (requiring man-
ual maneuvers), and less than three stools per week.
Functional constipation is commonly considered easily
preventable, with increased dietary fiber intake being a
safe and effective option. If left untreated, functional con-
stipation may develop into serious bowel disorders with
implications for work impairment, lost productivity, re-
duced health-related quality of life, and rising medical
costs [24,25]. For example, from 1958 to 1986, the average
number of doctor visits for constipation in the United
States was 2.5 million annually [26]. However, the fre-
quency of medical visits for constipation-related care has
increased considerably in the last 20 years, thus represent-
ing a growing economic burden for both the patient and
medical provider, with the number of physician visits to-
taling 4 million from 1993 through 1996 and 7.95 million
from 2001 through 2004 [27].
The objective of this research was to identify potential
cost savings, in terms of direct medical expenditures,
i.e., medical encounters and prescription and over-the-
counter (OTC) laxatives, associated with increased intakeof dietary fiber in the United States. To accommodate the
multiple sources of uncertainty in the required input pa-
rameters, the model was designed to be flexible and cap-
able of exploring a wide range of inputs. A base case as
well as multiple sensitivity analyses were tested and are
presented herein.
Methods
The decision-analytic model was developed using and
estimates the direct medical cost savings associated with
constipation among adults based on the following fac-
tors: (1) baseline dietary fiber consumption; (2) preva-
lence of constipation among those not meeting dietary
fiber intake recommendations; (3) proportion of those
likely to respond, in terms of alleviation of constipation-
associated symptoms, to increased dietary fiber intakes;
(4) estimated decrease in constipation prevalence associ-
ated with each 1 g/day increase of dietary fiber intake;
and (5) expected change in dietary fiber intake. The
medical costs prior to and following the hypothetical
intervention (i.e., increased dietary fiber intake) are com-
pared. All data included in this manuscript were ex-
tracted from the peer-reviewed literature and no original
research involving human subjects (including human
material or human data) was conducted; therefore, the
study was not subject to institutional review board re-
view and did not require written informed consent.
Two age populations are available in the model: chil-
dren (aged 5 to 17 years of age) and adults (aged 18 years
and above). The population of children 4 years of age
and younger is excluded from this model because there
is limited information on the prevalence of functional
constipation among infants and preschoolers [28] and
treatment patterns appear to differ for infants and pre-
schoolers compared to older children and adolescents
[29]. In addition, the limited available data on treatment
costs suggests substantial differences between infants
and preschoolers compared to older children, adolescents,
and adults (citation) and it is unknown, particularly
among infants, if increasing dietary fiber is a potential
treatment option. In this model, the user can select
pediatric, adult, or all as the population of interest. Chil-
dren 5 to 17 years are included in the model’s sensitivity
analyses, but not in the base case of the model because
there is more uncertainty around the model’s input pa-
rameters for children, although reasonable estimates were
used to populate the model.
Identification and definition of input parameters
The spreadsheet model includes inputs from multiple
sources. A full list of these sources and base case param-
eters are presented in Table 1. Many of the input param-
eters were obtained directly from the peer-reviewed
literature. As the table demonstrates, default values were







Adult, male 3% USDA, 2010 [2]
Adult, female 6% USDA, 2010 [2]
Pediatric, male 3% USDA, 2010 [2]
Pediatric, female 3% USDA, 2010 [2]
Population with constipation
Adult, male 4.6% Stewart et al., 1999 [22]
Adult, female 4.6% Stewart et al., 1999 [22]
Pediatric, male 4.6% Based on Stewart et al.,
1999 [22]









with each 1 g/day
increase in fiber intake









Adult, prescription $10,786.15 Mean of Mitra et al.,
2011 [31] and Nyrop et al.
2007 [32], inflated to 2012
Adult, OTC $566.54 Nyrop et al. 2007 [32],
inflated to 2012
Pediatric, prescription $3032.97 Liem et al., 2009 [33],
inflated to 2012
Change in fiber intake Increase of
9 g daily
Assumptionb
Abbreviations: USDA U.S. Department of Agriculture, OTC over-the-counter.
aRespond to fiber = alleviation of constipation.
bAssumed value of 9 g/day corresponds to the difference between the lower
limit of the fiber recommendation established by the IOM (25 g/day) and the
current mean intake in the population (16 g/day).
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range or add a value that is more specific or is outside of
the range.
Values for baseline dietary fiber intakes were derived from
publicly available estimates provided by the U.S. Depart-
ment of Agriculture (USDA), using data from the National
Health and Nutrition Examination Survey (NHANES)
2003–2006 [2]. Intake estimates from NHANES 2003–
2006 were used for consistency purposes, as the values
for the percentages of the population meeting dietary
fiber recommendations, defined by Adequate Intakes(which are intake levels established by the IOM and
considered to be adequate for the population) [2], were
from NHANES 2003–2006 [2]. Conservative estimates
of constipation prevalence, based on Rome diagnostic
criteria, for adults and children [22] were identified
from a systematic review of the epidemiologic literature
available in PubMed through January 2013. Although
other estimates exist, they are often based on self-
report, which may lead to higher estimates. In an effort
to be conservative in quantifying the population on
whom fiber intake might affect constipation, this model
uses what might be considered a low estimate of consti-
pation prevalence. Only one epidemiologic study identi-
fied provided sufficient data to estimate the percentage
reduction in constipation prevalence associated with an
increase in dietary fiber intake [18]; this study was con-
ducted among women in the Nurses’ Health Study aged
36 to 61 years of age. The dose–response estimate gen-
erated from this study was used as the default value in
the model (for each 1 gram increase in dietary fiber in-
take, the prevalence of constipation decreases by 1.9%).
A literature search was conducted to identify the costs
of treatment for patients with functional constipation.
Several studies were identified [31-35]; they were catego-
rized by the population studied and the treatment re-
quired into pediatric, adult OTC, and adult prescription.
Given the absence of data for the cost of pediatric non-
prescription care, the base case assumes that adult and
pediatric OTC annual costs are equivalent. Nevertheless,
the default value for pediatric constipation costs assume
that treatment costs are derived 100% from prescription
and 0% from OTC, as there are limited data on usage of
OTC laxatives in children, and there are only anecdotal
reports of off-label use of products not approved for
children. Only studies from the United States were in-
cluded, and costs were inflated to 2012 dollars using the
Bureau of Labor Statistics’ Medical Care Consumer Price
Index [36]. Table 2 presents sources for cost inputs for
the model.
A base case was created to reflect a plausible scenario,
given existing information. The base case is limited to the
adult population; for simplicity, assumptions for adult and
pediatric populations are presented here. For each input
parameter, sensitivity analyses were conducted, assuming
a range of plausible values. In the case of costs, the base
case values were increased and decreased by 50%. One
highly variable parameter required for the model is what
percent of the population will make particular dietary
changes. The model is designed to allow the user to spe-
cify the distribution of the population that falls into the
following categories: no additional dietary fiber, or an add-
itional 3, 5, 6, 7.5, 8, 9, 10, or 15 g/day of dietary fiber. The
base case assumed that all adults with dietary fiber intake
below recommended levels would increase their dietary
Table 2 Results and sensitivity analyses: cost savings of reduced constipation rates attributed to increased dietary
fiber intakes
Annual cost reduction Key parameters and/or change(s) in key parameters
$12.7 billion Base case
$1.1 billion No change in fiber intake for 75% of adults; 25% of adults increase fiber intake by 3 g daily
$13.2 billion Assumes that 1% of men and women currently meet fiber intake recommendation
$12.0 billion Assumes that 10% of men and women currently meet fiber intake recommendation
$7.5 billion Assumes that 50% of adults with constipation respond to fiber increase
$4.8 billion Assumes that 25% of adults with constipation require a prescription; 75% take over-the counter products
$20.0 billion Assumes that 1 g of increased fiber intake is associated with a 3% reduction in constipation
$19.3 billion Assumes that 7% of the adult population has constipation
$2.8 billion Assumes that 1% of the adult population has constipation
$19.5 billion Assumes that 4.0% of men and 10.2% of women have constipation {Markland, 2013 #632}
$21.9 billion Assumes that adults increase fiber intake by 15 g daily
$0.7 billion Pediatric population only; assumes 100% of the population increased fiber intake by 6 g daily
$83.9 billion Multivariate: best case - Assumes that 1% of adults meet fiber intake recommendations, 7% of adults have
constipation, 1 g of fiber intake is associated with a 3% reduction in constipation, all patients require a
prescription medication, 100% of adults increase fiber intake (by 15 g daily)
$2.3 million Multivariate: worst case - Assumes that 10% of adults meet fiber intake recommendations, 1% of adults have
constipation, 1 g of fiber intake is associated with a 1% reduction in constipation, all patients are treated with
an over the counter medication, only 25% of adults increase fiber intake (by 3 g daily)
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difference between the lower limit of the dietary fiber rec-
ommendation established by the IOM (25 g/day) [1] and
the current mean intake (16 g/day) [2]. The lower limit of
the dietary fiber recommendation for adult women was
selected as a conservative estimate, as the lower end of the
recommended dietary fiber intake range for adult men is
38 g/day [1]. The value of 25 g/day also aligns with the
Daily Value used on the Nutrition Facts Panel for a 2000
calorie diet. The proportion of cases treated with prescrip-
tion or OTC medications is an assumption, based on re-
view of published case series. The base case assumes that
75% of adults who present for care require a prescription
and that 100% of children require one. These values can
be modified by the user and were tested in sensitivity
analyses.
Results
Table 1 lists the input parameters used for the base case
of the model as well as the corresponding parameters
for the pediatric population. For example, the base case
assumes that 3% of the adult male population and 6% of
the adult female population meet dietary fiber recom-
mendations [2] and that 4.6% of adults (male and fe-
male) have functional constipation [22]. Sources are
provided for each parameter.
Table 2 presents results for the base case of the model
and selected sensitivity analyses. Under the base case as-
sumptions, the annual cost savings were estimated to be
$12.7 billion. Sensitivity analyses were based on varyingthe input parameters. The table presents the annual cost
reduction associated with each different scenario. As ex-
pected, results from the sensitivity analyses showed vari-
ation across the different input parameters, but all
plausible scenarios resulted in cost savings of at least $1
billion, with maximum savings associated with a success-
ful public health campaign that would result in substan-
tially increased dietary fiber intakes. With this assumption
of adults increasing dietary fibers intakes by 15 g/day,
more than $80 billion in annual savings could be achieved.
The proportion of adults with constipation in the base
case was set to 4.6% for all adults; a recent U.S. study
using a different methodology for identifying constipation
rates has suggested this value may be too low for women.
Thus, a sensitivity analysis used values from the most re-
cent NHANES analysis, which estimated rates were 4.0%
for men and 10.2% for women [37]. No input parameter
was identified as trivial, nor was any parameter identified
that dominated the sensitivity analysis. As shown in
Table 2, if only 1% of adults currently meet their dietary
fiber intake recommendation and all remaining individuals
who are not meeting recommendations increase their in-
take by 9 g daily, then the savings increases slightly to
$13.2 billion from the base case of $12.7 billion. If 10% of
adults already meet the recommendation, the savings, as
expected, is slightly smaller, at $12.0 billion. The last two
rows in Table 2 present results of multivariate sensitivity
analyses of best and worst case scenarios. The best case
scenario has the lowest proportion of the population
meeting dietary fiber intake recommendations, the highest
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intake; this scenario results in estimated savings of more
than $83 billion annually. The worst case scenario as-
sumes the opposite, that is, the highest rates of dietary
fiber intake along with the lowest rates of constipation
and the lowest constipation costs (i.e. use of over-the-
counter medications only). This scenario results in a mod-
est cost savings of just greater than $2 million. An analysis
of the potential cost savings among the pediatric popula-
tion projected a savings of $0.7 billion annually.
Discussion
Increased dietary fiber consumption for adults with
functional constipation is associated with a considerable
cost savings, likely exceeding $12 billion, with a possibil-
ity of exceeding $20 billion with small changes in the
model. The inclusion of the pediatric population adds
another small but substantial increment ($0.7 billion).
The finding that tens of billions of dollars in constipa-
tion costs could be averted through simple, realistic
changes in dietary practices is promising and highlights
the need for strategies to increase dietary fiber intakes.
These strategies should include efforts to ensure all indi-
viduals have access to fiber-rich foods as well as efforts
to modify individual dietary intake behavior (e.g., provid-
ing nutrition education and increasing awareness of the
health benefits of dietary fiber).
An important consideration from an economic stand-
point relates to the types of foods that individuals would
consume to obtain additional dietary fiber in their diets.
This analysis did not assume an additional cost for in-
creased dietary fiber consumption. Many foods that are
available in both conventional and fiber-enriched ver-
sions, such as ready-to-eat cereal and snack bars, are
comparably priced; in addition, there is a lack of data
showing that fiber-rich foods are more expensive than
lower-fiber foods [14]. Therefore, an additional cost was
considered unnecessary for the model. In other words,
the model assumes that consumers make simple substi-
tutions of one product for another similarly-priced prod-
uct that is otherwise nutritionally similar. This is
supported by findings from a recent study that demon-
strated how fiber intakes can be increased with simple,
small-step substitutions without affecting caloric intake
[38]. However, it is possible that a different pattern of
consumption would occur, i.e., consumers may replace
calorie-dense food items with low energy-dense food
items. For example, consumers may replace energy-
dense candy bars with fiber-rich cereal bars. In this case,
dietary fiber intake is not the only factor that changes,
but intakes of total energy and saturated fat may de-
crease, while intakes of other dietary components gener-
ally found in fiber-rich foods, such as magnesium [39],
may increase. Furthermore, overall diet quality mayimprove as a result of replacing calorie-dense foods
items with lower energy-dense, fiber-rich food items
[13,40]. The implications are that there can be many
other related health and economic outcomes affected. A
substitution of a similar product might yield results such
as this model calculated; in contrast, the replacement of
one type of food for a dissimilar one may mean this
model, focused only on constipation, grossly underesti-
mates savings in direct medical costs that result from
the unintended consequence of eliminating other prod-
ucts from the diet in favor of fiber. A related consider-
ation is that not all types of dietary fiber are equally
effective at enhancing regularity. For example, wheat
bran fiber in particular has been shown to promote
bowel regularity [39,41]. However, the assumptions for
the model were based on data from the Nurses’ Health
Study [18], which evaluated total dietary fiber. Should
other data sources or estimates become available, these
can be incorporated as new input parameters into the
existing model. In addition, the current model allows for
the exploration of a number of possibilities, including
varying dietary fiber intakes and reductions in constipa-
tion prevalence associated with each additional gram of
dietary fiber intake.
Some considerations are warranted for the basis of the
model parameters used in this study. Regarding the epi-
demiologic data used for input parameters, misclassifica-
tion, misdiagnosis, and failure to diagnose (as not all
individuals who suffer from constipation seek medical
care) have hampered efforts to ascertain accurate preva-
lence and incidence of functional constipation. Even
when validated surveys have been used to define consti-
pation, the estimates can differ greatly based on method
and whether frequency, consistency, or a combination of
the two are considered [42]. By using a fairly strict cri-
terion for constipation, these findings may underesti-
mate the number of potential patients and thus the
potential cost savings. In addition, certain populations
are often excluded from the types of surveys that esti-
mate prevalence, including the institutionalized elderly
and neonates, as well as patients who are suffering from
opioid- or other drug-induced constipation or for pa-
tients where polypharmacy is necessary [43-45]. The
diagnostic criteria for constipation have also changed
over time, and dietary fiber intake estimates are based
on self-report. Furthermore, the estimate used for the
decrease in constipation associated with each 1 g/day in-
crease in dietary fiber intake was derived from a single
study of adult women; further analysis to refine the value
or to provide separate estimates by age and sex would
be welcomed. Finally, population-level assumptions were
made about baseline dietary fiber intake and constipa-
tion prevalence. No data were available to identify diet-
ary fiber intake for those with and without constipation.
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tions, it should be noted that the model assumes that a
1.9% decrease in constipation would result in a 1.9% re-
duction in constipation-related costs. Although plausible,
this assumption does not account for a variety of scenar-
ios. For instance, this change in constipation might de-
crease the severity of constipation from requiring a
prescription to being treated by OTCs, or it might move
an individual who uses OTCs often to using them rarely,
or it might mean those with already close-to-acceptable
dietary fiber intake might have no constipation costs at all.
More likely it means a combination of these possibilities
will exist in the population rather than just one. Last, cost
estimates are sparse and limited to direct medical costs,
without considering important indirect costs such as those
related to lost work or school days per month [46,47].
Therefore, limiting the model to direct medical costs savings
yields a conservative estimate for constipation-related cost.
Nonetheless, the model developed here demonstrates a con-
siderable cost savings associated with a simple, feasible, and
realistic approach to reduce the economic burden from
constipation, namely increasing dietary fiber consumption.
Conclusion
The public health implications of increasing dietary fiber
intake to recommended levels for gastrointestinal health
and chronic disease prevention are significant. Accumulat-
ing evidence indicates that greater dietary fiber intakes re-
duce risk for type 2 diabetes [4,5], cardiovascular disease
[5-7], certain cancers [8-10], weight gain [11,12], obesity
[11], and diverticular disease [13,14], as well as functional
constipation [15-20]. In 2010, the Dietary Guidelines for
Americans classified dietary fiber as a nutrient of concern
because more than 90% of U.S. adults and children failed
to meet their daily dietary fiber recommendations [3].
Given that the vast majority of Americans are not meeting
recommendations yet the potential benefits of increasing
intakes for both public health and cost savings are sub-
stantial, more comprehensive efforts are needed to align
intakes with recommendations. These efforts should in-
clude strategies to increase the supply, availability, and
consumer demand of fiber-rich foods, such as whole
grains, vegetables, nuts, and legumes, and to provide
higher fiber varieties of the foods individuals are pres-
ently consuming, including ready-to-eat cereals.
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